141 related articles for article (PubMed ID: 38329812)
1. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38329812
[TBL] [Abstract][Full Text] [Related]
2. Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome.
Weh KM; Howard CL; Zhang Y; Tripp BA; Clarke JL; Howell AB; Rubenstein JH; Abrams JA; Westerhoff M; Kresty LA
bioRxiv; 2023 Aug; ():. PubMed ID: 37662411
[TBL] [Abstract][Full Text] [Related]
3. Proanthocyanidins mitigate bile acid-induced changes in GSTT2 levels in a panel of racially diverse patient-derived primary esophageal cell cultures.
Weh KM; Turgeon DK; Rubenstein JH; Clarke JL; Howell AB; Chang AC; Kresty LA
Mol Carcinog; 2022 Mar; 61(3):281-287. PubMed ID: 34758158
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
[TBL] [Abstract][Full Text] [Related]
5. Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.
Ferrer-Torres D; Nancarrow DJ; Steinberg H; Wang Z; Kuick R; Weh KM; Mills RE; Ray D; Ray P; Lin J; Chang AC; Reddy RM; Orringer MB; Canto MI; Shaheen NJ; Kresty LA; Chak A; Wang TD; Rubenstein JH; Beer DG
Gastroenterology; 2019 Apr; 156(5):1404-1415. PubMed ID: 30578782
[TBL] [Abstract][Full Text] [Related]
6. Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model.
Zhang Y; Weh KM; Tripp BA; Clarke JL; Howard CL; Sunilkumar S; Howell AB; Kresty LA
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139823
[TBL] [Abstract][Full Text] [Related]
7. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
[TBL] [Abstract][Full Text] [Related]
8. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
[TBL] [Abstract][Full Text] [Related]
9. Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.
Kresty LA; Weh KM; Zeyzus-Johns B; Perez LN; Howell AB
Oncotarget; 2015 Oct; 6(32):33438-55. PubMed ID: 26378019
[TBL] [Abstract][Full Text] [Related]
10. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
[TBL] [Abstract][Full Text] [Related]
11. From Reflux Esophagitis to Esophageal Adenocarcinoma.
Souza RF
Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
[TBL] [Abstract][Full Text] [Related]
12. Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells.
Kresty LA; Howell AB; Baird M
J Agric Food Chem; 2008 Feb; 56(3):676-80. PubMed ID: 18211022
[TBL] [Abstract][Full Text] [Related]
13. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
14. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
15. Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett's Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations.
Zaramella A; Arcidiacono D; Nucci D; Fabris F; Benna C; Pucciarelli S; Fassan M; Fantin A; De Re V; Cannizzaro R; Realdon S
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447211
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
[TBL] [Abstract][Full Text] [Related]
17. Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models.
Korbut E; Krukowska K; Magierowski M
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328735
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA alterations in Barrett's esophagus, esophageal adenocarcinoma, and esophageal adenocarcinoma cell lines following cranberry extract treatment: Insights for chemoprevention.
Kresty LA; Clarke J; Ezell K; Exum A; Howell AB; Guettouche T
J Carcinog; 2011; 10():34. PubMed ID: 22279419
[TBL] [Abstract][Full Text] [Related]
19. Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma.
Zaidi AH; Kelly LA; Kreft RE; Barlek M; Omstead AN; Matsui D; Boyd NH; Gazarik KE; Heit MI; Nistico L; Kasi PM; Spirk TL; Byers B; Lloyd EJ; Landreneau RJ; Jobe BA
BMC Cancer; 2016 Feb; 16():52. PubMed ID: 26841926
[TBL] [Abstract][Full Text] [Related]
20. Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma.
Mirvish SS
Cancer Lett; 1997 Aug; 117(2):161-74. PubMed ID: 9377544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
